CVS Group (LON:CVSG) Releases Earnings Results

CVS Group (LON:CVSG) released its earnings results on Thursday. The company reported GBX 85.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a return on equity of 5.35% and a net margin of 2.31%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Price Performance

CVS Group stock opened at GBX 1,228.55 on Thursday. The company has a debt-to-equity ratio of 92.34, a quick ratio of 0.90 and a current ratio of 1.07. CVS Group has a 52 week low of GBX 1,062 and a 52 week high of GBX 1,648. The stock has a market capitalization of £835.05 million, a P/E ratio of 17.83, a price-to-earnings-growth ratio of 1.77 and a beta of 1.07. The stock has a fifty day moving average of GBX 1,289.88 and a 200-day moving average of GBX 1,230.

Insider Activity at CVS Group

In related news, insider Robin Alfonso bought 768 shares of the company’s stock in a transaction dated Thursday, August 6th. The stock was purchased at an average price of GBX 1,294 per share, with a total value of £9,937.92. Also, insider David Wilton bought 1,500 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was bought at an average cost of GBX 1,276 per share, with a total value of £19,140. Insiders have acquired 3,860 shares of company stock valued at $4,956,696 over the last ninety days. 1.48% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms recently commented on CVSG. Jefferies Financial Group boosted their price target on CVS Group from GBX 1,350 to GBX 1,400 and gave the company a “hold” rating in a research note on Friday, July 31st. Berenberg Bank reiterated a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday. Shore Capital Group reissued a “hold” rating and issued a GBX 1,400 target price on shares of CVS Group in a report on Thursday. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,700 price target on shares of CVS Group in a report on Monday, July 27th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of GBX 1,666.67.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.